Pathstone Holdings’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163M Buy
642,722
+250,759
+64% +$58.4M 0.48% 37
2026
Q1
$95.8M Buy
391,963
+23,747
+6% +$5.53M 0.38% 43
2025
Q4
$76.2M Sell
368,216
-3,197
-0.9% -$632K 0.29% 53
2025
Q3
$68.9M Buy
371,413
+1,713
+0.5% +$293K 0.26% 60
2025
Q2
$56.4M Buy
369,700
+24,119
+7% +$3.71M 0.22% 68
2025
Q1
$57.3M Sell
345,581
-2,151
-0.6% -$337K 0.25% 70
2024
Q4
$50.3M Sell
347,732
-24,680
-7% -$3.82M 0.22% 72
2024
Q3
$60.4M Buy
372,412
+3,130
+0.8% +$499K 0.27% 66
2024
Q2
$54M Sell
369,282
-16,120
-4% -$2.4M 0.24% 69
2024
Q1
$61M Buy
385,402
+32,817
+9% +$5.22M 0.28% 57
2023
Q4
$55.4M Buy
+352,585
New +$54.1M 0.3% 58

Other funds holding JNJ

Pathstone Holdings's JNJ Position: Q2 2026 in Review

Pathstone Holdings increased its Johnson & Johnson (JNJ) stake by 64% in Q2 2026, buying an estimated $58.4M and bringing the position to 642,722 shares worth $163M. The position accounts for 0.48% of the portfolio, ranked #37.

Pathstone Holdings first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Pathstone Holdings held 642,722 shares of Johnson & Johnson worth $163M as of Q2 2026.
  • Pathstone Holdings bought 250,759 Johnson & Johnson shares in Q2 2026, an estimated $58.4M.
  • Johnson & Johnson made up 0.48% of Pathstone Holdings's portfolio in Q2 2026, its #37 holding.
  • Pathstone Holdings first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.